Clinical Trials Logo

Clinical Trial Summary

There are 3 levels of severity of anoxo-ischemic encephalopathy (EAI): mild, moderate and severe. Therapeutic hypothermia is beneficial in children with moderate EAI. It is ineffective in severe EAI and may be deleterious if there is no EAI. He continues to question his interest in light EAIs.

There are few studies on the becoming of children with a mild anoxic-ischemic encephalopathy and not set hypothermia.

The main hypothesis of the study is that term newborns with anoxo-ischemic encephalopathy who did not require therapeutic hypothermia have normal psychomotor development at 2 years.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03744481
Study type Observational
Source Hospices Civils de Lyon
Contact
Status Completed
Phase
Start date May 19, 2019
Completion date August 2, 2019

See also
  Status Clinical Trial Phase
Completed NCT02231060 - Study for the Improvement of Long-Term Outcome Prediction in Patients in Coma After Cardiac Arrest
Recruiting NCT05851391 - buRst-supprESsion TO Stop Refractory Status Epilepticus Post-cardiac Arrest Phase 2